{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:42:16Z","timestamp":1788550936539,"version":"build-2803163510"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171295"],"award-info":[{"award-number":["82171295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0042"],"award-info":[{"award-number":["2023YFS0042"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["24LCYJZD04 24YWYL03"],"award-info":[{"award-number":["24LCYJZD04 24YWYL03"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2024MS513"],"award-info":[{"award-number":["2024MS513"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>The high incidence and mortality rates of cardiovascular and cerebrovascular diseases make them a significant global health challenge. Antiplatelet drugs play a central role in the prevention and treatment of these diseases. Despite the wide range of available antiplatelet drugs, antiplatelet drug resistance is not rare. So optimizing drug use through personalized treatment strategies to achieve maximum therapeutic benefit remains a major challenge in clinical practice. Non-coding RNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have made significant progress in understanding their regulatory roles in drug resistance, becoming a frontier area of current research. In addition to the regulatory functions of non-coding RNAs, emerging studies have highlighted the role of RNA modifications, such as N6-methyladenosine (m6A), in the regulation of gene expression and cellular processes involved in antiplatelet drug resistance. These modifications contribute to the stability, splicing, and translation of RNA, further influencing their roles in drug resistance mechanisms. In recent years, significant progress has been made in the research of non-coding RNAs and RNA modifications, revealing their crucial roles in the mechanisms of antiplatelet drug resistance. This review focuses on the latest advancements in non-coding RNA research related to antiplatelet drug resistance and explores the emerging field of RNA modifications. It analyzes potential underlying mechanisms and discusses future research directions, aiming to provide new theoretical support and research perspectives for personalized precision antiplatelet.<\/jats:p>","DOI":"10.3389\/fgene.2025.1618105","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:14:08Z","timestamp":1757304848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms and recent advances in non-coding RNAs and RNA modifications in antiplatelet drug resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Ping","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quandan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/molecules26071987","article-title":"The role of genetic polymorphism and other factors on clopidogrel resistance (CR) in an Asian population with coronary heart disease (CHD)","volume":"26","author":"Akkaif","year":"2021","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2015-06-649434","article-title":"Circular RNA enrichment in platelets is a signature of transcriptome degradation","volume":"127","author":"Alhasan","year":"2016","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"b1927","DOI":"10.1136\/bmj.b1927","article-title":"Clopidogrel. Bleeding and resistance","volume":"338","author":"Ball","year":"2009","journal-title":"Bmj"},{"key":"B6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.clinbiochem.2016.04.017","article-title":"Aspirin resistance May be identified by miR-92a in plasma combined with platelet distribution width","volume":"49","author":"Binderup","year":"2016","journal-title":"Clin. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clinbiochem.2018.12.009","article-title":"Identification of aspirin resistance using a PDW-miR92a-score: validation in an intermittent claudication cohort","volume":"64","author":"Binderup","year":"2019","journal-title":"Clin. Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40360-017-0189-7","article-title":"Head to head comparison of prasugrel versus ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials","volume":"18","author":"Bundhun","year":"2017","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/pwcb4016","article-title":"Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model","volume":"28","author":"Carroll","year":"2024","journal-title":"Health Technol. Assess."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"787881","DOI":"10.3389\/fbioe.2021.787881","article-title":"Circular RNA: biosynthesis in vitro","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3892\/etm.2016.3278","article-title":"Expression of miRNA-26a in platelets is associated with clopidogrel resistance following coronary stenting","volume":"12","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10557-019-06855-3","article-title":"Platelet MicroRNA 365-3p expression correlates with high On-treatment platelet reactivity in coronary artery disease patients","volume":"33","author":"Chen","year":"2019","journal-title":"Cardiovasc Drugs Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.12102\/j.issn.1672-1349.2021.02.036","article-title":"Study on the correlation between aspirin resistance and platelet miR-223 in patients with acute cerebral infarction","volume":"19","author":"Chen","year":"2021","journal-title":"Chin. J. Integr. Med. Cardio\/Cerebrovascular Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","article-title":"Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial","volume":"81","author":"Chen","year":"2024","journal-title":"JAMA Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9322188","DOI":"10.1155\/2023\/9322188","article-title":"Lower plasma miR-223 level is associated with clopidogrel resistance in acute coronary syndrome: a systematic review and meta-analysis","volume":"2023","author":"Cheng","year":"2023","journal-title":"J. Interv. Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"bbab601","DOI":"10.1093\/bib\/bbab601","article-title":"CRAFT: a bioinformatics software for custom prediction of circular RNA functions","volume":"23","author":"Dal Molin","year":"2022","journal-title":"Brief. Bioinform"},{"key":"B22","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European stroke organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack","volume":"7","author":"Dawson","year":"2022","journal-title":"Eur. Stroke J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-0716-1170-8_7","article-title":"MicroRNA databases and tools","volume":"2257","author":"de Amorim","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.amjcard.2013.05.067","article-title":"Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke","volume":"112","author":"Dinicolantonio","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.13602\/j.cnki.jcls.2016.01.09","article-title":"The expression of urinary miR-126 in patients with coronary heart disease and its relationship with aspirin resistance","volume":"34","author":"Fan","year":"2016","journal-title":"Chin. J. Clin. Laboratory Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2008.01105.x","article-title":"The genetics of antiplatelet drug resistance","volume":"75","author":"Feher","year":"2009","journal-title":"Clin. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","article-title":"High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis","volume":"376","author":"Fiolaki","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pharmthera.2011.01.011","article-title":"Aspirin resistance: effect of clinical, biochemical and genetic factors","volume":"130","author":"Fitzgerald","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"Floyd","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.prostaglandins.2015.03.011","article-title":"Antiplatelet drug resistance: molecular insights and clinical implications","volume":"120","author":"Floyd","year":"2015","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1027892","DOI":"10.3389\/fcvm.2022.1027892","article-title":"The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention","volume":"9","author":"Giantini","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/s0140-6736(20)30325-1","article-title":"Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial","volume":"395","author":"Gimbel","year":"2020","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2023.07.025","article-title":"Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC state-of-the-art review","volume":"82","author":"Greco","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/s0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1001-9057.2020.01.009","article-title":"Predictive value of platelet microRNA-223 and microRNA-21 on clopidogrel resistance after percutaneous coronary intervention in patients with coronary heart disease","volume":"37","author":"Guo","year":"2020","journal-title":"J. Clin. INTER Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1161\/01.Cir.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1003569","DOI":"10.1371\/journal.pgen.1003569","article-title":"Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs","volume":"9","author":"Hangauer","year":"2013","journal-title":"PLoS Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/s0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1161\/strokeaha.121.034378","article-title":"Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel: subanalysis of the CSPS.com trial","volume":"52","author":"Hoshino","year":"2021","journal-title":"Stroke"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3000605241230429","DOI":"10.1177\/03000605241230429","article-title":"Epoxidase inhibitor-aspirin resistance and the relationship with genetic polymorphisms: a review","volume":"52","author":"Hou","year":"2024","journal-title":"J. Int. Med. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2200860","DOI":"10.1080\/09537104.2023.2200860","article-title":"Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease","volume":"34","author":"Hu","year":"2023","journal-title":"Platelets"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e70258","DOI":"10.1111\/cns.70258","article-title":"Understanding drug interactions in antiplatelet therapy for atherosclerotic vascular disease: a systematic review","volume":"31","author":"Huang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.podrm.2021.10.003","article-title":"Ticagrelor","volume":"47","author":"Kabil","year":"2022","journal-title":"Relat. Methodol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"Cd008076","DOI":"10.1002\/14651858.CD008076.pub2","article-title":"Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin","volume":"2011","author":"Kamal","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/10600280211073009","article-title":"Antiplatelet use in ischemic stroke","volume":"56","author":"Kamarova","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"11317","DOI":"10.3390\/ijms231911317","article-title":"Aspirin resistance in vascular disease: a review highlighting the critical need for improved point-of-care testing and personalized therapy","volume":"23","author":"Khan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"Jama"},{"key":"B50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12920-024-01936-1","article-title":"Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance","volume":"17","author":"Kim","year":"2024","journal-title":"BMC Med. Genomics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijcard.2015.10.098","article-title":"Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity","volume":"203","author":"Kok","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/19418744241228630","article-title":"Dual antiplatelet non-responder: resistance to clopidogrel and ticagrelor","volume":"14","author":"Kuhn","year":"2024","journal-title":"Neurohospitalist"},{"key":"B54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/cpt.2797","article-title":"Comparative effectiveness of ticagrelor, prasugrel, and clopidogrel for secondary prophylaxis in acute coronary syndrome: a propensity score-matched cohort study","volume":"113","author":"Kumar","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2459\/jcm.0000000000000691","article-title":"Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment","volume":"19","author":"La","year":"2018","journal-title":"J. Cardiovasc Med. Hagerst."},{"key":"B56","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets","volume":"16","author":"Landry","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/neurintsurg-2021-017638","article-title":"Ticagrelor resistance: a case series and algorithm for management of non-responders","volume":"14","author":"Laurent","year":"2022","journal-title":"J. Neurointerv Surg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/15476286.2017.1307484","article-title":"A fly view on the roles and mechanisms of the m(6)A mRNA modification and its players","volume":"14","author":"Lence","year":"2017","journal-title":"RNA Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3969\/j.issn.1673-5765.2024.08.013","article-title":"Interpretation of the Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023","volume":"19","author":"Li","year":"2024","journal-title":"Chin. J. Neurology"},{"key":"B62","first-page":"2677","article-title":"Correlation between antiplatelet resistance and recurrent cardiac ischemic events of patients with acute myocardial infarction","volume":"92","author":"Li","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00228-017-2298-z","article-title":"Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients","volume":"73","author":"Li","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3000605211016209","DOI":"10.1177\/03000605211016209","article-title":"MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction","volume":"49","author":"Li","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/eurjpc\/zwac285","article-title":"Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: findings from 2019 global burden of disease study","volume":"30","author":"Li","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.eclinm.2024.102758","article-title":"Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021","volume":"75","author":"Li","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/15476286.2018.1502590","article-title":"MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery","volume":"15","author":"Lin","year":"2018","journal-title":"RNA Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e00751","DOI":"10.1002\/prp2.751","article-title":"The expression profile of platelet-derived miRNA in coronary artery disease patients with clopidogrel resistance","volume":"9","author":"Lin","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nsmb.3162","article-title":"N6-methyladenosine\u2013encoded epitranscriptomics","volume":"23","author":"Liu","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3969\/j.issn.1005-9202.2017.15.028","article-title":"The expression of miR-126 in the blood circulation of patients with coronary heart disease and its relationship with aspirin resistance","volume":"37","author":"Liu","year":"2017","journal-title":"Chin. J. Gerontology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12864-018-4456-9","article-title":"Ouroboros resembling competitive endogenous loop (ORCEL) in circular RNAs revealed through transcriptome sequencing dataset analysis","volume":"19","author":"Liu","year":"2018","journal-title":"BMC Genomics"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1055\/s-0039-1692681","article-title":"miR-34b-3p may promote antiplatelet efficiency of aspirin by inhibiting thromboxane synthase expression","volume":"119","author":"Liu","year":"2019","journal-title":"Thromb. Haemost."},{"key":"B73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.thromres.2019.12.016","article-title":"Platelet-derived miRNAs as determinants of the antiplatelet response in clopidogrel-treated patients with ACS","volume":"186","author":"Liu","year":"2020","journal-title":"Thromb. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e021129","DOI":"10.1161\/jaha.121.021129","article-title":"Influence of GAS5\/MicroRNA-223-3p\/P2Y12 axis on clopidogrel response in coronary artery disease","volume":"10","author":"Liu","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"B75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12920-015-0109-x","article-title":"Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing","volume":"8","author":"Lopez","year":"2015","journal-title":"BMC Med. Genomics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3791\/67154","article-title":"Ultrasensitive cDNA library preparation for next-generation sequencing of MicroRNAs from small extracellular vesicles","volume":"220","author":"Loudig","year":"2025","journal-title":"J. Vis. Exp."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1373\/clinchem.2017.285767","article-title":"Small ncRNA-Seq results of human tissues: variations depending on sample integrity","volume":"64","author":"Ludwig","year":"2018","journal-title":"Clin. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1160\/th16-04-0316","article-title":"Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment","volume":"116","author":"Massimi","year":"2016","journal-title":"Thromb. Haemost."},{"key":"B79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-7046-9_4","article-title":"MicroRNAs: biomarkers, diagnostics, and therapeutics","volume":"1617","author":"MicroRNAs","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/cpt.2754","article-title":"Cost effectiveness of pharmacogenetic testing for drugs with clinical pharmacogenetics implementation consortium (CPIC) guidelines: a systematic review","volume":"112","author":"Morris","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/atvbaha.123.319759","article-title":"Platelet RNA biomarker of ticagrelor-responsive genes is associated with platelet function and cardiovascular events","volume":"44","author":"Myers","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00392-021-01866-3","article-title":"Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis","volume":"110","author":"Orban","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-13-1426-1_6","article-title":"Circular RNAs act as miRNA sponges","volume":"1087","author":"Panda","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-019-0981-3","article-title":"Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels","volume":"19","author":"Parker","year":"2020","journal-title":"Cardiovasc Diabetol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2017.07.011","article-title":"Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS","volume":"157","author":"Peng","year":"2017","journal-title":"Thromb. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e007811","DOI":"10.1161\/circinterventions.119.007811","article-title":"Clopidogrel pharmacogenetics","volume":"12","author":"Pereira","year":"2019","journal-title":"Circ. Cardiovasc Interv."},{"key":"B88","doi-asserted-by":"publisher","first-page":"11791","DOI":"10.1021\/acs.analchem.8b03557","article-title":"Next generation sequencing analysis of total small noncoding RNAs from low input RNA from dried blood sampling","volume":"90","author":"Pirritano","year":"2018","journal-title":"Anal. Chem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1424473","DOI":"10.1080\/20013078.2018.1424473","article-title":"Selective release of circRNAs in platelet-derived extracellular vesicles","volume":"7","author":"Preu\u00dfer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"B90","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ihj.2014.08.012","article-title":"Clopidogrel resistance: the way forward","volume":"66","author":"Ray","year":"2014","journal-title":"Indian Heart J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1161\/circulationaha.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the antiplatelet drug resistances and ischemic events study","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"key":"B92","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ijcard.2010.10.040","article-title":"Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world","volume":"155","author":"Ruff","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.031","article-title":"Aspirin resistance in ischemic stroke: insights using short thrombelastography","volume":"22","author":"Sambu","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/eurheartj\/ehz917","article-title":"Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study","volume":"41","author":"Schnorbus","year":"2020","journal-title":"Eur. Heart J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"117364","DOI":"10.1016\/j.lfs.2020.117364","article-title":"Coding SNPs in hsa-miR-1343-3p and hsa-miR-6783-3p target sites of CYP2C19 modulates clopidogrel response in individuals with cardiovascular diseases","volume":"245","author":"Sharma","year":"2020","journal-title":"Life Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.thromres.2013.02.015","article-title":"Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity","volume":"131","author":"Shi","year":"2013","journal-title":"Thromb. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12539-016-0166-7","article-title":"microRNAs databases: developmental methodologies, structural and functional annotations","volume":"9","author":"Singh","year":"2017","journal-title":"Interdiscip. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e017120","DOI":"10.1161\/jaha.120.017120","article-title":"Low miR-19b-1-5p expression is related to aspirin resistance and major adverse Cardio- cerebrovascular events in patients with acute coronary syndrome","volume":"10","author":"Singh","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejvs.2017.03.024","article-title":"Antiplatelet resistance in ischaemic stroke patients","volume":"54","author":"Spanos","year":"2017","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/j.jtha.2023.09.013","article-title":"Antiplatelet strategies: past, present, and future","volume":"21","author":"Stanger","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1055\/s-0039-1693702","article-title":"MicroRNAs as regulators and biomarkers of platelet function and activity in coronary artery disease","volume":"119","author":"Stojkovic","year":"2019","journal-title":"Thromb. Haemost."},{"key":"B102","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1055\/s-0040-1722226","article-title":"Circulating MicroRNAs and monocyte-platelet aggregate formation in acute coronary syndrome","volume":"121","author":"Stojkovic","year":"2021","journal-title":"Thromb. Haemost."},{"key":"B103","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom10020187","article-title":"Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity","volume":"10","author":"Sun","year":"2020","journal-title":"Biomolecules"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/cells11142256","article-title":"Large-scale profiling on lncRNAs in human platelets: correlation with platelet reactivity","volume":"11","author":"Sun","year":"2022","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","first-page":"20240899","DOI":"10.1515\/med-2024-0899","article-title":"METTL3-mediated methylation of CYP2C19 mRNA May aggravate clopidogrel resistance in ischemic stroke patients","volume":"19","author":"Tan","year":"2024","journal-title":"Open Med. (Wars)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41401-018-0041-7","article-title":"Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy","volume":"40","author":"Tang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"B108","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/eurheartj\/ehv443","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","volume":"37","author":"Udell","year":"2016","journal-title":"Eur. Heart J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","volume":"9","author":"Valgimigli","year":"2024","journal-title":"JAMA Cardiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/ehjcvp\/pvac037","article-title":"Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome","volume":"9","author":"van den Broek","year":"2022","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B112","article-title":"The regulatory mechanism of miR-126-3p on the antiplatelet reactivity","volume-title":"ACS patients treated with ticagrelor [master]","author":"Wang","year":"2022"},{"key":"B113","doi-asserted-by":"publisher","first-page":"580783","DOI":"10.3389\/fphar.2020.580783","article-title":"Long non-coding RNA H19 positively associates with aspirin resistance in the patients of cerebral ischemic stroke","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/circresaha.111.300539","article-title":"Circulating microRNAs as novel biomarkers for platelet activation","volume":"112","author":"Willeit","year":"2013","journal-title":"Circ. Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"9","DOI":"10.11817\/j.issn.1672-7347.2019.01.002","article-title":"Differential expression of lncRNA in patients with coronary artery disease plus clopidogrel resistance","volume":"44","author":"Xie","year":"2019","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2217\/epi-2021-0204","article-title":"Multiomics analysis identifies key genes and pathways related to N6-methyladenosine RNA modification in ovarian cancer","volume":"13","author":"Xu","year":"2021","journal-title":"Epigenomics"},{"key":"B118","doi-asserted-by":"publisher","first-page":"177156","DOI":"10.1016\/j.ejphar.2024.177156","article-title":"Identification of hsa_circ_0076957 and miR-4512-targeted COL19A1 as regulators in clopidogrel resistance among stable coronary heart disease patients through comprehensive circRNA and miRNA analysis","volume":"986","author":"Xu","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"583215","DOI":"10.3389\/fgene.2020.583215","article-title":"Clopidogrel resistance is associated with DNA methylation of genes from whole blood of humans","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Genet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13148-023-01602-w","article-title":"Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance","volume":"15","author":"Yu","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/pbi.13149","article-title":"N6-methyladenosine regulatory machinery in plants: composition, function and evolution","volume":"17","author":"Yue","year":"2019","journal-title":"Plant Biotechnol. J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000517811","article-title":"Platelet miR-107 participates in clopidogrel resistance after PCI treatment by regulating P2Y12","volume":"145","author":"Zhang","year":"2022","journal-title":"Acta Haematol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3969\/j.issn.1009-0126.2023.02.008","article-title":"Effect of RNA m6A methylation on aspirin responsiveness in elderly patients","volume":"25","author":"Zhang","year":"2023","journal-title":"Chin. J. Geriatric Heart Brain Vessel Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/09537104.2018.1457781","article-title":"Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model","volume":"30","author":"Zhou","year":"2019","journal-title":"Platelets"},{"key":"B125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"","journal-title":"Mol. Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/09537104.2019.1696455","article-title":"microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients","volume":"31","author":"Zhou","year":"","journal-title":"Platelets"},{"key":"B127","doi-asserted-by":"publisher","first-page":"254","DOI":"10.11915\/j.issn.1671-5403.2021.04.053","article-title":"Correlation of functional gene polymorphism of platelet-derived miR-126 with antiplatelet reactivity of clopidogrel and outcome in acute coronary syndrome patients","volume":"20","author":"Zhou","year":"2021","journal-title":"Chin. J. Multiple Organ Dis. Elder."},{"key":"B128","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12959-024-00620-9","article-title":"Platelet-derived circFAM13B associated with anti-platelet responsiveness of ticagrelor in patients with acute coronary syndrome","volume":"22","author":"Zou","year":"2024","journal-title":"Thromb. J."},{"key":"B129","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00439-016-1642-1","article-title":"New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach","volume":"135","author":"Zufferey","year":"2016","journal-title":"Hum. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1618105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:18:17Z","timestamp":1757305097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1618105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":129,"alternative-id":["10.3389\/fgene.2025.1618105"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1618105","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"article-number":"1618105"}}